Pfizer Inc
F:PFE
Pfizer Inc
F:PFE
Price:
23.1
EUR
1.54%
Market Closed
Market Cap:
€131.3B
Relative Value
The Relative Value of one
PFE
stock under the Base Case scenario is
28.97
EUR.
Compared to the current market price of 23.1 EUR,
Pfizer Inc
is
Undervalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PFE
Relative Value
Base Case
28.97
EUR
Undervaluation 20%
Multiples Across Competitors
PFE Competitors Multiples
Pfizer Inc Competitors
Pfizer Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pfizer Inc
F:PFE
|
154B EUR | 2.4 | 19.6 | 7.3 | 9.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 15.3 | 48.2 | 32.5 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
283.4B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.5 | 16 | 10 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.8B GBP | 5.1 | 31.7 | 15.1 | 22.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.8 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124B USD | 2.6 | 17.6 | 6.9 | 8.8 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.4B GBP | 2.7 | 15.4 | 7.8 | 11.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
